- Home
- EVEX vs KNSA Comparison
EVEX vs KNSA Comparison
Compare EVEX & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVEX
- KNSA
- Stock Information
- Founded
- EVEX 2020
- KNSA 2015
- Country
- EVEX United States
- KNSA United Kingdom
- Employees
- EVEX N/A
- KNSA N/A
- Industry
- EVEX Aerospace
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- EVEX Industrials
- KNSA Health Care
- Exchange
- EVEX Nasdaq
- KNSA Nasdaq
- Market Cap
- EVEX 2.2B
- KNSA 2.1B
- IPO Year
- EVEX N/A
- KNSA 2018
- Fundamental
- Price
- EVEX $6.43
- KNSA $27.64
- Analyst Decision
- EVEX Strong Buy
- KNSA Strong Buy
- Analyst Count
- EVEX 3
- KNSA 6
- Target Price
- EVEX $6.67
- KNSA $39.33
- AVG Volume (30 Days)
- EVEX 542.0K
- KNSA 998.0K
- Earning Date
- EVEX 08-05-2025
- KNSA 07-29-2025
- Dividend Yield
- EVEX N/A
- KNSA N/A
- EPS Growth
- EVEX N/A
- KNSA N/A
- EPS
- EVEX N/A
- KNSA N/A
- Revenue
- EVEX N/A
- KNSA $481,166,000.00
- Revenue This Year
- EVEX N/A
- KNSA $37.21
- Revenue Next Year
- EVEX N/A
- KNSA $5.32
- P/E Ratio
- EVEX N/A
- KNSA N/A
- Revenue Growth
- EVEX N/A
- KNSA 59.45
- 52 Week Low
- EVEX $2.33
- KNSA $17.82
- 52 Week High
- EVEX $7.70
- KNSA $30.69
- Technical
- Relative Strength Index (RSI)
- EVEX 49.60
- KNSA 46.35
- Support Level
- EVEX $6.27
- KNSA $28.19
- Resistance Level
- EVEX $7.48
- KNSA $29.58
- Average True Range (ATR)
- EVEX 0.49
- KNSA 0.93
- MACD
- EVEX -0.14
- KNSA -0.06
- Stochastic Oscillator
- EVEX 11.55
- KNSA 27.88
About EVEX Eve Holding Inc.
Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment , a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.